Small study questions ketamine's value as cancer pain drug

09/25/2012 | ABC (Australia) · Daily Telegraph (Australia), The

The anaesthetic drug ketamine's benefit in treating cancer pain may be outweighed by its side effects, according to Flinders University research in the Journal of Clinical Oncology. The small study of 185 patients found no better pain control than with a placebo as well as higher rates of toxicity and side effects.

View Full Article in:

ABC (Australia) · Daily Telegraph (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX